Free Trial

CastleKnight Management LP Cuts Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

CastleKnight Management LP cut its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 39.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 78,900 shares of the company's stock after selling 50,800 shares during the quarter. CastleKnight Management LP owned 0.16% of Nu Skin Enterprises worth $544,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in NUS. Meeder Asset Management Inc. bought a new position in shares of Nu Skin Enterprises during the 4th quarter worth about $25,000. US Bancorp DE lifted its stake in Nu Skin Enterprises by 424.2% in the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after purchasing an additional 6,037 shares during the last quarter. Signaturefd LLC raised its stake in shares of Nu Skin Enterprises by 536.8% during the fourth quarter. Signaturefd LLC now owns 8,087 shares of the company's stock valued at $56,000 after acquiring an additional 6,817 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Nu Skin Enterprises by 2,412.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock valued at $57,000 after buying an additional 7,888 shares during the period. Finally, Bank of Montreal Can purchased a new position in shares of Nu Skin Enterprises during the fourth quarter valued at about $80,000. 82.84% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th.

View Our Latest Report on Nu Skin Enterprises

Nu Skin Enterprises Trading Up 8.5%

NUS traded up $0.58 on Monday, reaching $7.42. 665,041 shares of the company traded hands, compared to its average volume of 836,421. Nu Skin Enterprises, Inc. has a one year low of $5.32 and a one year high of $14.00. The firm has a fifty day simple moving average of $6.73 and a two-hundred day simple moving average of $6.95. The company has a market cap of $369.14 million, a P/E ratio of -2.51 and a beta of 0.92. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The firm had revenue of $364.49 million for the quarter, compared to analyst estimates of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Friday, May 30th will be issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 3.23%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines